JD Health reports 15.90 percent revenue growth while JD Health stock costs EUR 4.54

Published on 10/20/2026 at 20:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half margin reached 8.50 percent on August 13, 2026. JD Health stock costs EUR 4.54 in trading on October 20, 2026 at 7:57 p.m. CEST.

Revenue and margin facts

JD Health reported first-half 2026 revenue growth of 15.90 percent on August 13, 2026.
Non-IFRS operating profit rose 40.30 percent to CNY 3.50 billion, while the margin reached 8.50 percent.
JD Health stock costs EUR 4.54 at Lang & Schwarz on October 20, 2026 at 7:57 p.m. CEST.

JD Health, KYG5074A1004, Illustration mit AI erstellt.

JD Health reported first-half 2026 revenue of CNY 40.90 billion, up 15.90 percent from the prior-year period, while the stock stood at EUR 4.54 at Lang & Schwarz on October 20, 2026 at 7:57 p.m. CEST. GMT Eight reported the results on August 13, 2026.

Profit growth outpaced revenue

The stronger number came from profitability. Non-IFRS operating profit rose 40.30 percent year over year to CNY 3.50 billion in the first half of 2026, according to GMT Eight. The operating margin increased from 7.00 percent in the first half of 2025 to 8.50 percent in the first half of 2026, giving investors a clearer measure of earnings quality than revenue growth alone.

Hong Kong listing sets the market frame

JD Health is listed on the Hong Kong Stock Exchange under ticker 6618, according to Global Banking and Finance. The Hong Kong listing closed at HKD 38.56 on October 16, 2026, while the company had a market capitalization of HKD 120.40 billion as of October 15, 2026. The separate euro quotation is useful for investors tracking the stock from Germany, but the Hong Kong price remains the home-market reference.

Margins face the next test

The first-half figures put margin durability ahead of simple sales expansion. JD Health operates an online healthcare platform spanning pharmaceutical retail, medical services and health management, while its interim update also described more than 450 JD Pharmacy stores across ten cities and medical-insurance payment services in 40 cities. These operating figures connect the margin improvement with a broader service network.

Comparison with peers

JD Health's first-half 2026 revenue rose 15.90 percent and its non-IFRS operating profit increased 40.30 percent. The company had HKD 120.40 billion in market capitalization on October 15, 2026. The earnings pattern is therefore defined by faster profit growth than revenue growth, with the operating margin at 8.50 percent in the first half of 2026.

Price remains the daily anchor

The Lang & Schwarz quotation placed JD Health at EUR 4.54 on October 20, 2026 at 7:57 p.m. CEST. The latest reported operating figures provide the business context: CNY 40.90 billion of first-half revenue and CNY 3.50 billion of non-IFRS operating profit.

The further course of trading is shown by the continuously updated real-time quote of JD Health stock.